Collectively, these corroborate the rationale that Nrf1 acts as a bona fide dominant tumor repressor, by intrinsic inhibition of the Wnt/β-catenin and their independent signaling networks involved in cancer development, progression, and malignancy. The gene discussed is NRF1; the disease is neoplasm.